Page last updated: 2024-08-17

apomorphine and cyclopentane

apomorphine has been researched along with cyclopentane in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andén, NE; Bédard, P1
Altemus, KL; Cepeda, C; Colwell, CS; Levine, MS1
Assié, MB; Auclair, A; Bardin, L; Consul-Denjean, N; Depoortère, R; Newman-Tancredi, A; Sautel, F1

Other Studies

3 other study(ies) available for apomorphine and cyclopentane

ArticleYear
Influences of cholinergic mechanisms on the function and turnover of brain dopamine.
    The Journal of pharmacy and pharmacology, 1971, Volume: 23, Issue:6

    Topics: Animals; Apomorphine; Atropine; Basal Ganglia; Brain; Catalepsy; Cyclopentanes; Dopamine; Hallucinogens; Haloperidol; Humans; Mandelic Acids; Norepinephrine; Parasympatholytics; Piperidines; Rats; Scopolamine; Trihexyphenidyl

1971
Regulation of N-methyl-D-aspartate-induced toxicity in the neostriatum: a role for metabotropic glutamate receptors?
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Feb-06, Volume: 93, Issue:3

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Apomorphine; Cyclopentanes; GABA Agonists; Hippocampus; In Vitro Techniques; Kainic Acid; Male; Microscopy, Video; Motor Activity; N-Methylaspartate; Neostriatum; Neurotoxins; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reference Values

1996
F15063, a potential antipsychotic with dopamine D(2)/D(3) antagonist, 5-HT(1A) agonist and D(4) partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 2007, Volume: 375, Issue:4

    Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Benzofurans; Benzylamines; Cyclopentanes; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Mice; Receptors, Dopamine D3; Receptors, Dopamine D4; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists

2007